Sinan Albear, MD
Ophthalmology · Madison Heights, MINPI 1609371822
Payments from drug & device makers
What this record shows
This record is dominated by other: $13,809 of the $15,221 with a category attached, or 90.7%. Alcon accounts for 91.1% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $14,081, more than ten times the $25 reported in 2020. Among ophthalmology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 35 payments — averaging $434.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$14K
- NEW World Medical,inc.$314
- Glaukos Corporation$181
- Sight Sciences, Inc.$175
- Tarsus Pharmaceuticals, Inc.$145
- AbbVie$132
- plus $403 from 10 others
What the payments were for
- Food & beverage$1,4129%
- Other$13,80991%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 4 | $13,871 |
| NEW World Medical,inc. | 5 | $314 |
| Glaukos Corporation | 2 | $181 |
| Sight Sciences, Inc. | 3 | $175 |
| Tarsus Pharmaceuticals, Inc. | 2 | $145 |
| AbbVie | 4 | $132 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $102 |
| Biotissue Holdings Inc. | 3 | $71 |
| Bausch & Lomb Americas Inc. | 3 | $67 |
| Sun Pharmaceutical Industries Inc. | 2 | $36 |
| Aerie Pharmaceuticals, Inc. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Dompe US, Inc. | 1 | $23 |
| Boston Scientific | 1 | $22 |
| Ocular Therapeutix, Inc. | 1 | $19 |
| Thea Pharma Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARGOS$13,809
- Wavelight Refractive Suite$13,809
- XDEMVY$122
- OMNI(R) SURGICAL SYSTEM (US)$121
- Tecnis IOL$102
How this compares
$15,221 in reported general payments places this provider in the 95th percentile of 674 ophthalmology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 126 | $92,116 |
| Cyclosporine | 137 | $42,960 |
| XiidraLifitegrast | 42 | $28,276 |
| RocklatanNetarsudil Mesylat/Latanoprost | 42 | $23,056 |
| LumiganBimatoprost | 50 | $15,854 |
| CombiganBrimonidine Tartrate/Timolol | 29 | $15,070 |
| RhopressaNetarsudil Mesylate | 42 | $14,469 |
| Prednisolone Acetate | 252 | $6,267 |
| Latanoprost | 590 | $5,303 |
| Alphagan PBrimonidine Tartrate | 16 | $4,078 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 237 | $3,838 |
| Ketorolac Tromethamine | 193 | $2,650 |
| Brimonidine Tartrate | 304 | $2,388 |
| MoxifloxacinMoxifloxacin Hcl | 105 | $2,287 |
| Timolol Maleate | 114 | $1,566 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Combigan, Alphagan P | $132 | $127,118221 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan, Rhopressa | $25 | $37,52584 claims |
| Bausch & Lomb Americas Inc.Xiidra | $67 | $28,27642 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 674 ophthalmology providers in Michigan.
Other ophthalmology in Madison Heights
- Manjool ShahAnn Arbor$609K
- Gregory KatzYpsilanti$401K
- Timothy PageBirmingham$250K
- David ZacksAnn Arbor$177K
- Scott WesthouseGrand Rapids$138K
- Bret HughesDetroit$123K
- Pradeepa YoganathanDetroit$115K
- Jason MillerAnn Arbor$104K
- David TukelDearborn$91K
- Yannis PaulusAnn Arbor$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.